Cardiometabolic Risk
Reference materials for in-vitro investigation of cardiovascular and metabolic risk markers affected by incretin-receptor signaling.
For Research Use Only
This brief describes analytical reference materials supplied by R3TA LLC for in-vitro laboratory research. It is not a protocol and contains no dosing, administration, or therapeutic guidance. Not for human or animal consumption.
Preclinical and clinical reports associate GLP-3 with favorable shifts in lipid profiles, blood pressure, and inflammatory markers.
R3TA reference materials are used in endothelial-cell, hepatocyte, and macrophage models to study surrogate cardiometabolic endpoints.
No claim of cardiovascular benefit is made. Materials are supplied For Research Use Only.
Representative in-vitro endpoints
- —Endothelial-cell nitric oxide and inflammatory cytokine endpoints
- —Hepatocyte lipid-export and apolipoprotein expression panels
- —Macrophage foam-cell formation and cholesterol-efflux assays
- —Vascular smooth-muscle cell proliferation and migration models
Handling & storage
- —Store lyophilized at −20 °C
- —Reconstitute immediately prior to assay
- —Aliquot to avoid freeze–thaw degradation
- —Record lot and expiry in the laboratory notebook
Analytical documentation
- —RP-HPLC purity chromatogram per lot
- —LC-MS identity confirmation
- —Water content by Karl Fischer where specified